Risk factors for non-traditional chronic kidney disease in men from central provinces, Panama
Main Article Content
Abstract
Background: non-traditional chronic kidney disease (CKDnt) affects young men in agricultural activities in Central America.
Objectives: to identify risk factors associated with CKDnt in healthy men exposed to heat stress and agrochemicals in central provinces, Panama.
Methods: observational, cross-sectional, and analytical study conducted between January and June 2024. Thirty-five exposed subjects (farmers/heat stress) were compared with 35 non-exposed subjects. Anthropometric measurements, blood tests, and exposure questionnaires were performed.
Results: the exposed group presented significantly higher levels of uric acid and a lower estimated glomerular filtration rate compared to the control group. Inadequate use of personal protective equipment was documented in 85 % of those exposed.
Conclusions: the findings suggest that recurrent dehydration and pesticide exposure are key determinants. There are early markers of kidney damage in the healthy exposed population, requiring urgent preventive interventions.
Downloads
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
References
1. CENCAM (2019). Consortium for the Epidemic of Nephropathy in Central America and Mexico. Disponible en: http://www.regionalnephropathy.org/?page_id=233e
2. Courville K, Bustamante N, Hurtado B, Pecchio M, Rodríguez C, Núñez-Samudio V, et al. Chronic kidney disease of nontraditional causes in central Panama. BMC Nephrol. 2022;23:275.
3. Wesseling, C., Crowe, J., Hogstedt, C., Jakobsson, K., Wegman, D., Lucas, R. (Eds). (2013). Mesoamerican Nephropathy. Report from the First International Research Workshop on MeN. Heredia, Costa Rica: Serie Informes Técnicos IRET N°7. ISBN 978-9968-924-06-1. Disponible en: https://cencam.net/wp-content/uploads/2021/02/MeN-Report-2012.pdf
4. MINSA, Ministerio de Salud. Plan Estratégico Nacional Para La Prevención Y El Control Integral De Las Enfermedades No Transmisibles Y Sus Factores De Riesgo, 2014. Disponible en: Microsoft Word - PLAN ESTRATEGICO ENT revision 12 mayo 2016
5. Rodríguez F, Cuero C, Delgado E, Camargo I, Tunon R. Diagnóstico de la enfermedad renal crónica y factores de riesgo asociados en áreas seleccionadas de la provincia de Coclé, Panamá. Rev Med Panamá; 2014:31-8.
6. Motta JA, Ortega-Paz LG, Gordón CA, Gómez B, Castillo E, Herrera Ballesteros V, et al. Diabetes mortality in Panama and related biological and socioeconomic risk factors. Rev Panam Salud Publica. 2013;34:114-20.
7. MINSA, Ministerio de Salud (2017). En Panamá aumentan los casos de pacientes con enfermedades renales crónicas (laestrella.com.pa). Disponible en: https://www.laestrella.com.pa/nacional/190617/casos-panama-aumentan-pacientes-enfermedades
8. Castillo E, Rodríguez M, Jaén A, Courville K. Enfermedad renal crónica de causa no tradicional: artículo de revisión. Rev med cient. 2024;37:21-30.
9. Sanchez Polo V, Garcia-Trabanino R, Rodriguez G, Madero M. Mesoamerican nephropathy (MeN): What we know so far. Int J Nephrol Renovasc Dis. 2020;13:261-72.
10. Leibler JH, Tuz-Zahra F, García-Trabanino R, Friedman DJ, Amador Velázquez JJ, Jarquín E, et al. Longitudinal estimated GFR trajectories among workers at high risk for CKD of unknown etiology. Kidney Int Rep. 2025;10:3395-406.
11. Petropoulos ZE, Keogh SA, Jarquín E, López-Pilarte D, Amador Velázquez JJ, García-Trabanino R, et al. Heat stress and heat strain among outdoor workers in El Salvador and Nicaragua. J Expo Sci Environ Epidemiol. 2023;33:622-30.
12. Wijkström J, González-Quiroz M, Hernandez M, Trujillo Z, Hultenby K, Ring A, et al. Renal morphology, clinical findings, and progression rate in Mesoamerican nephropathy. Am J Kidney Dis. 2017;69:626-36.
13. Trabanino RG, Aguilar R, Silva CR, Mercado MO, Merino RL. Nefropatía terminal en pacientes de un hospital de referencia en El Salvador [End-stage renal disease among patients in a referral hospital in El Salvador]. Rev Panam Salud Publica. 2002;12:202-6.
14. Courville K, Nuñez-Samudio V, Bustamante N, Cumbrera R, Pecchio M, Pimentel G, et al. Prevalencia de anemia en pacientes con enfermedad renal crónica en estadio 4 y evaluación de eventos cardiovasculares. Rev. Colomb. Nefrol. 2024;11:e794.
15. Brisot E, Leprêtre PM, Hamza E, Fourdinier O, Brigant B, Ouled-Haddou H, et al. Uremic toxins levels are associated with miR-223 in chronic kidney disease-associated anemia. Noncoding RNA Res. 2025;13:121-30.
16. WHO: global status report on alcohol and health and treatment of substance use disorders. 2025. Disponible en: https://iris.who.int/bitstream/handle/10665/377960/9789240096745-eng.pdf.
17. Garcia-Garcia G, Jha V, Tao Li PK, Garcia-Garcia G, Couser WG, Erk T, et al. Chronic kidney disease (CKD) in disadvantaged populations. Clin Kidney J. 2015;8:3-6.
18. Mendley SR, Levin A, Correa-Rotter R, Joubert BR, Whelan EA, Curwin B, et al. Chronic kidney diseases in agricultural communities: report from a workshop. Kidney Int. 2019;96:1071-6.
19. Courville K, Polo VS, Arena R, Borelli G, Hu L, Di Nunzio M, et al. Chronic Kidney Disease in migrants: from epidemiology to challenges. Kidney Int Rep. 2026;11:103726.
20. Kshirsagar AV, Zeitler EM, Weaver A, Franceschini N, Engel LS. Environmental Exposures and Kidney Disease. Kidney360. 2022;3:2174-82.
21. Ameh OI, Ekrikpo UE, Kengne AP. Preventing CKD in low- and middle-income countries: a call for urgent action. Kidney Int Rep. 2019;5:255-62.